Nirmatrelvir/ritonavir is not current recommended for patients with CKD stage 4 or 5, but low-dose regimens could avoid adverse events, according to the authors of a recent editorial.
Persistent vs undetectable PSA after salvage radical prostatectomy is significantly associated with an increased risk for biochemical recurrence, metastasis, and death, investigators reported.
Clinicians need to provide older patients with chronic kidney disease with more information about the risks they face from COVID-19 and the effect of the illness on treatment options, according to investigators.
Cytoreductive partial nephrectomy and robotic radiosurgery appear to have a place in the treatment of metastatic renal cell carcinoma, research findings suggest.
A report in the Journal of the National Cancer Institute presents findings from the first assessment of the real-world safety of abiraterone and enzalutamide in a national sample of Medicare beneficiaries with advanced prostate cancer.